Camp4 Therapeutics Corporation
Officers & Directors
MICHAEL BURDIEK joined us as Executive Vice President in 2006 and was appointed
President of our Wireless DataCom segment in 2007. Mr. Burdiek was appointed Chief
Operating Officer in 2008 and was promoted to President and COO in 2010. In 2011,
he was promoted to CEO and was appointed to our Board of Directors. Prior to joining
CalAmp, Mr. Burdiek was the President and CEO of Telenetics Corporation, a publicly
held manufacturer of data communications products. Earlier in his career, Mr.
Burdiek held a variety of executive management positions with Comarco, Inc., a
publicly held company. Mr. Burdiek began his career as a design engineer with
Hughes Aircraft Company.
GARO SARKISSIAN joined us in 2005 and serves as Senior Vice President, Corporate
Development. Prior to joining CalAmp, from 2003 to 2005 he served as Principal
and Vice President of Business Development for Global Technology Investments
(GTI), a private equity firm. Prior to GTI, from 1999 to 2003, Mr. Sarkissian
held senior management and business development roles at California Eastern
Laboratories, a private company developing and marketing radio frequency (RF),
microwave and optical components. Mr. Sarkissian began his career as an RF engineer
over a span of 10 years for M/A Com and NEC.
KURTIS BINDER joined us in July 2017 and serves as our Executive Vice President
and Chief Financial Officer. Prior to joining our company, he served as the
Chief Financial Officer at VIZIO, Inc., a television and consumer electronics
company headquartered in the United States since April 2010. Prior to joining
VIZIO, Mr. Binder served as the Chief Accounting Officer for Applied Medical
Resources, Inc. since December 2009. Mr. Binder was also employed in the assurance
practice of Ernst & Young LLP from October 1997 to July 2009 and served
as an Assurance and Advisory Business Services Partner.
Camp4 Therapeutics Corporation currently has 48 employees.
News about Camp4 Therapeutics Corporation Key Personnel |
The Future of Biotech and Tech: CAMP4 Therapeutics and CalAmp Navigate Transition and Innovation Amid Industry ChallengesIn an era defined by rapid technological advancement and groundbreaking medical innovation, the biotechnology and consumer electronics sectors are under immense pressure to evolve and remain competitive. Two companies at the forefront of these changes, CAMP4 Therapeutics (CAMP4) and CalAmp, are strategically addressing their respective challenges while positioning themselves for future growth. Recent corporate updates from CAMP4 and a financial restructuring by CalAmp underscore their commitment to innovation and long-term success.CAMP4 Therapeutics: Pioneering gene regulation for the fut...
|
|
